Latest News about GSK
Recent news which mentions GSK
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
January 18, 2022
From Benzinga
2 Best COVID-19 Growth Stocks to Own in 2022
January 17, 2022
From Motley Fool
From MarketWatch
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
January 15, 2022
From Benzinga
3 Top Biotech Stocks to Buy Right Now
January 15, 2022
From Motley Fool
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
January 14, 2022
Tickers
GSK
From Benzinga
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
From Motley Fool
GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
January 13, 2022
From Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
From Benzinga
From Benzinga
From MarketWatch
CureVac Outlines Upcoming Catalysts For Vaccine Programs
January 10, 2022
From Benzinga
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
From Motley Fool
The 3 Smartest Tech Stocks to Buy in 2022 and Beyond
January 05, 2022
From Motley Fool
Happy new year? Drug prices rising as 2022 begins
January 05, 2022
From MarketWatch
Why iTeos Therapeutics Topped the Market Today
January 03, 2022
From Motley Fool
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
Johnson & Johnson Stock: Bull vs. Bear
December 27, 2021
From Motley Fool
From Benzinga
My 3 Favorite Under-the-Radar Healthcare Stocks for 2022
December 21, 2021
From Motley Fool
Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option
December 21, 2021
From Benzinga
7 Stocks to Buy if Covid-19 Becomes Endemic
December 20, 2021
From InvestorPlace
From Benzinga
2 Cheap Stocks With 10X Potential to Buy in 2022
December 16, 2021
From Motley Fool
Why Vir Biotechnology Stock Surged Today
December 15, 2021
From Motley Fool
Drug makers move forward with new COVID-19 booster candidates amid omicron’s spread and mass booster campaigns
December 15, 2021
From MarketWatch
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Why Are Vir Biotech Shares Gaining Today?
December 15, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.